StemRIM (TSE:4599) Construction In Progress : 円0 Mil (As of Jan. 2024)

View and export this data going back to 2019. Start your Free Trial

What is StemRIM Construction In Progress?

StemRIM's quarterly construction in progress declined from Jul. 2023 (円10 Mil) to Oct. 2023 (円0 Mil) but then stayed the same from Oct. 2023 (円0 Mil) to Jan. 2024 (円0 Mil).

StemRIM's annual construction in progress declined from Jul. 2021 (円10 Mil) to Jul. 2022 (円10 Mil) but then stayed the same from Jul. 2022 (円10 Mil) to Jul. 2023 (円10 Mil).

StemRIM Construction In Progress Historical Data

The historical data trend for StemRIM's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StemRIM Construction In Progress Chart

StemRIM Annual Data

Trend

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Construction In Progress

Get a 7-Day Free Trial

5.72

6.46

9.59

StemRIM Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Construction In Progress	Get a 7-Day Free Trial															-	-	9.59	-	-

StemRIM Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

StemRIM (TSE:4599) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemRIM Inc (TSE:4599) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

N/A

Address

7-15 Ayato Bio Incubator 3rd floor, Ayato Asagi 7-chome, Prefecture Ibaraki City, Osaka, JPN, 567-0085

Website

https://www.stemrim.com

StemRIM Inc is a biotechnology company engaged in developing regeneration-guided medicines. The business activity of the group includes research, development, manufacture, and sales of pharmaceuticals and medical devices and products such as gene therapy that activate stem cells existing in the body and induce regeneration of damaged tissue.

StemRIM (TSE:4599) Headlines

No Headlines